See if Italian patients with cancer experience MRI anxiety and how a translated questionnaire works

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional study will translate and culturally adapt the MRI-Anxiety Questionnaire into Italian for cancer patients receiving whole-body MRI. It will recruit 175 adult participants at the European Institute of Oncology and use forward-backward translation, followed by validation by comparing the Italian MRI-AQ scores with the MRI-Fear Survey Schedule. The primary analysis will assess internal consistency to determine non-inferiority to the original instrument. The goal is to provide a validated, Italian-language tool to measure MRI-related anxiety in oncology patients and support improved patient management. The study discusses the relevance of WB-MRI in cancer care and acknowledges factors that influence patient anxiety, including claustrophobia, noise, and concern about outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cancer patients who will perform a WB-MRI in their clinical path
* Age ≥ 18 years
* Patients able to speak and read the local language(s) fluently.
* Patients with no concomitant neurological or psychiatric disorders.
* Acceptance and signature of informed consent

Exclusion Criteria:

* Absolute contraindication to WB-MRI
* Previous cancer-related medical treatments or other treatments that could have altered patients' cognition

Where it's running

• European Institute of Oncology, Milan
  Milan, Mi, Italy Recruiting

Study contacts

• Study coordinator: Giuseppe Petralia, PhD
• Email: giuseppe.petralia@ieo.it
• Phone: +39 0257489037

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding what patients want from NSCLC treatment monitoring

  Researchers are testing how patients with non-small cell lung cancer feel about and prefer monitoring their symptoms during treatment, with input from patients, caregivers, and clinicians.

  Recruiting European Institute of Oncology · Milan, mI · NCT07909343

• Single-Port Robotic Lobectomy for Early-Stage NSCLC

  This study tests the safety and outcomes of using the da Vinci Single-Port system for lobectomy and lymph node dissection in people with early-stage non-small cell lung cancer.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07790406

• Disparities in Mental Health Screening and Support for Cancer Patients and Families

  This study tests whether cancer patients and their families across Europe have equal access to mental health screening and support services.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07691281

• Melanoma Brain Metastases Treated with Stereotactic Radiosurgery and Systemic Therapy

  This study looks at how stereotactic radiosurgery for melanoma brain metastases works when patients are also receiving immunotherapy or targeted therapy.

  Recruiting at 2 sites European Institute of Oncology · Milan, Italy and 1 other locations · NCT07691255

• Predictive biomarkers for immunotherapy in endometrial cancer

  This study tests molecular and epigenetic features to see if they can predict which endometrial cancer patients will respond to immune checkpoint inhibitors.

  Recruiting European Institute of Oncology · Milan, Italy · NCT07690540

• Diet quality and nutrient adequacy in vegetarian and vegan women at a Milan cancer institute

  This study tests whether 3 months of personalized vegetarian-focused nutrition counselling improves body composition, activity, and quality of life in vegan, vegetarian, and semi-vegetarian women aged 18–64 attending care at the European Institute of Oncology.

  Recruiting European Institute of Oncology · Milan · NCT07638839

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.